Patent Information:
For Information, Contact:
Barny Cox
UCL Business PLC
b.cox@uclb.com
Keywords:
Autoimmune & Inflammation
Infection & Vaccines

Dengue Virus High-Throughput Fluorescent Assay

Case ID:
12-001
Web Published:
01/03/2011
Description:

Available For: Non-exclusive licenses.
<h2>Summary</h2>
We have developed a novel fluorescent assay for the screening of small molecules targeting dengue virus.
<h2>The Technology and its Advantages</h2>
Our technology is based on stable cell lines expressing a replicon of dengue virus, optimised for assessing drug efficacy in vitro through incorporation of a fluorescent reporter element.
<h2>Market opportunity</h2>
Dengue hemorrhagic fever is a flavivirus with the major disease burden occurring in South East Asia, the Americas and the Western Pacific, but recent cases have been reported in Florida. It is possible that environmental warming may see increased distribution of dengue cases.
<h2>Further Information</h2>
Please contact Dr Barny Cox, Senior Business Manager |T: +44(0)20 7679 9160 |E: b.cox@uclb.com

© 2017. All Rights Reserved. Powered by Inteum